Home › NCT07224126

Technology Assisted Treatment of Trichotillomania: Open Trial

Technology Assisted Treatment for Trichotillomania: Open Trial

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* 18 years of age (criterion 1a) with a diagnosis of TTM (criterion 1b)
* Must reportEnglish as their primary language (criterion 2)
* Report no current pharmacological or psychosocial intervention targeting TTM symptoms OR a6-week course of either intervention modality without change in frequency,intensity, or dosage (criterion 3)
* Reliable and consistent access to the internet and/or mobile device permitting the participant to meet withsomeone virtually for 90 min.
* Must report owning/access to a mobilephone running on Apple's operating system (iOS)
* Identifies a support person that is able to be contacted is an emergency arises.
* Agrees to allow the Kent State research team to share home address, mobile number, andalternate number/email with HabitAware, Inc., for purposes of mailing Keen2device and setting up Keen2 system.

Exclusion Criteria:

* Current suicidal/homicidal ideation, intent, or plan
* a diagnosis of another psychiatric condition that may impeded a participant's ability to fully utilize the app (e.g., psychotic disorder, major depressive disorder)

About the study

This open-label feasibility trial evaluates the use of the Keen2 awareness bracelet for adults with trichotillomania (hair-pulling disorder). Participants will use the bracelet for eight weeks. During the first four weeks, they will wear the device and log contextual information (such as emotions, location, and activity) after each detected hair-pulling episode. Based on these data, participants will then receive tailored predictive alerts designed to support use of stimulus control, competing responses, and coping strategies. The study will assess usability, adherence, and changes in self-reported hair-pulling severity and awareness.

What is being tested

• Keen2 Predictive Awareness Bracelet (behavioral)

Sponsor: HabitAware Inc. · Participants: 10 · Started: Sep 15, 2025

Contact the study team

• Christopher Flessner, PhD · Phone: (330) 672-2200

Official record on ClinicalTrials.gov — NCT07224126

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.